Aarhus University logo / Aarhus Universitets logo
Funding and study opportunities have been made available from a variety of sources in Denmark, Finland, Norway and Sweden for researchers and students displaced from Ukraine. Read more.
The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.
The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.
The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.
Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice.
Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.
DANDRITE Team Leader Gilles Vanwalleghem studies communication between the gut and the brain, and how disruption of such can happen and affect immune function and behavior.
International research consortia have analyzed common and rare DNA variants in hundreds of thousands of people, revealing clearest genetic signals yet for schizophrenia risk.
NCMM is delighted to announce that Dr Biswajyoti Sahu has been recruited as a new group leader for Precision Medicine. Dr Sahu will join us in September 2022 from the University of Helsinki, Finland.
Page 2 of 38.
